| UniProt ID | CCR7_HUMAN | |
|---|---|---|
| UniProt AC | P32248 | |
| Protein Name | C-C chemokine receptor type 7 | |
| Gene Name | CCR7 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 378 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein. |
|
| Protein Description | Receptor for the MIP-3-beta chemokine. Probable mediator of EBV effects on B-lymphocytes or of normal lymphocyte functions.. | |
| Protein Sequence | MDLGKPMKSVLVVALLVIFQVCLCQDEVTDDYIGDNTTVDYTLFESLCSKKDVRNFKAWFLPIMYSIICFVGLLGNGLVVLTYIYFKRLKTMTDTYLLNLAVADILFLLTLPFWAYSAAKSWVFGVHFCKLIFAIYKMSFFSGMLLLLCISIDRYVAIVQAVSAHRHRARVLLISKLSCVGIWILATVLSIPELLYSDLQRSSSEQAMRCSLITEHVEAFITIQVAQMVIGFLVPLLAMSFCYLVIIRTLLQARNFERNKAIKVIIAVVVVFIVFQLPYNGVVLAQTVANFNITSSTCELSKQLNIAYDVTYSLACVRCCVNPFLYAFIGVKFRNDLFKLFKDLGCLSQEQLRQWSSCRHIRRSSMSVEAETTTTFSP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 36 | N-linked_Glycosylation | TDDYIGDNTTVDYTL CCCCCCCCCEECHHH | 32.22 | UniProtKB CARBOHYD | |
| 37 | O-linked_Glycosylation | DDYIGDNTTVDYTLF CCCCCCCCEECHHHH | 32.70 | OGP | |
| 38 | O-linked_Glycosylation | DYIGDNTTVDYTLFE CCCCCCCEECHHHHH | 20.03 | OGP | |
| 42 | O-linked_Glycosylation | DNTTVDYTLFESLCS CCCEECHHHHHHHHC | 22.10 | OGP | |
| 65 | Phosphorylation | AWFLPIMYSIICFVG HHHHHHHHHHHHHHH | 9.46 | - | |
| 66 | Phosphorylation | WFLPIMYSIICFVGL HHHHHHHHHHHHHHH | 6.52 | - | |
| 151 | Phosphorylation | MLLLLCISIDRYVAI HHHHHHHHHHHHHHH | 19.89 | 22817900 | |
| 155 | Phosphorylation | LCISIDRYVAIVQAV HHHHHHHHHHHHHHH | 7.18 | - | |
| 202 | Phosphorylation | LYSDLQRSSSEQAMR HHHHHCCCCHHHHHH | 25.84 | 24719451 | |
| 342 | Ubiquitination | NDLFKLFKDLGCLSQ HHHHHHHHHHCCCCH | 63.58 | - | |
| 356 | Phosphorylation | QEQLRQWSSCRHIRR HHHHHHHHHCHHHHH | 15.95 | 15054093 | |
| 357 | Phosphorylation | EQLRQWSSCRHIRRS HHHHHHHHCHHHHHH | 16.53 | 15054093 | |
| 364 | Phosphorylation | SCRHIRRSSMSVEAE HCHHHHHHCCCEEEE | 22.12 | 30108239 | |
| 365 | Phosphorylation | CRHIRRSSMSVEAET CHHHHHHCCCEEEEE | 17.17 | 30108239 | |
| 367 | Phosphorylation | HIRRSSMSVEAETTT HHHHHCCCEEEEEEC | 20.82 | 27080861 | |
| 372 | Phosphorylation | SMSVEAETTTTFSP- CCCEEEEEECCCCC- | 36.17 | 15054093 | |
| 373 | Phosphorylation | MSVEAETTTTFSP-- CCEEEEEECCCCC-- | 18.49 | 15054093 | |
| 374 | Phosphorylation | SVEAETTTTFSP--- CEEEEEECCCCC--- | 33.01 | 15054093 | |
| 375 | Phosphorylation | VEAETTTTFSP---- EEEEEECCCCC---- | 21.74 | 15054093 | |
| 377 | Phosphorylation | AETTTTFSP------ EEEECCCCC------ | 27.84 | 15054093 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 155 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CCR7_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CCR7_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CCL19_HUMAN | CCL19 | physical | 9153236 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-151, AND MASSSPECTROMETRY. | |